EDMUS

Collongues N, Marignier R, Zéphir H, Papeix C, Fontaine B, Blanc F, Rodriguez D, Fleury M-C, Vukusic S, Pelletier J, Audoin B, Thouvenot E, Camu W, Barroso B, Ruet A, Brochet B, Vermersch P, Confavreux C and de Sèze J. Long term follow-up of neuromyelitis optica with a pediatric onset. Arch Neurol. 2010, in the press.

Marignier R, Chenevier F, Rogemond V, Sillevis Smitt P, Renoux C, Cavillon G, Androdias G, Vukusic S, Graus F, Honnorat J and Confavreux C. Metabotropic Glutamate Receptor Type 1 Autoantibody–Associated Cerebellitis. A Primary Autoimmune Disease? Arch Neurol. 2010; 67: 627-630.

Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C and de Seze J. Neuromyelitis optica in France: A multicenter study of 125 patients.Neurology 2010; 74: 736-742.

Zéphir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M, Rudolf G, Marignier R, Vukusic S, Confavreux C, Vermersch P and de Seze J. Is neuromyelitis optica asociated with human leucocyte antigen? Multiple Sclerosis 2009; 15: 571-579.

Renoux C, Vukusic S, Confavreux C. The natural history of multiple sclerosis with childhood onsest. Clinical Neurology and Neurosurgery 2008; 110: 897-904.

Confavreux C, Ritleng C, Debouverie M, Durand-Dubief F, Marignier R, Androdias G, Laforest L, van Ganse E, Vukusic S. Defining the natural history of MS: the need for complete data and rigorous definitions. Answer to Dr Tremlett et al. Multiple sclerosis 2008; 14: 1144-1147.

Confavreux C. Defining the natural history of MS: the need for complete data and rigorous definitions. Multiple sclerosis 2008; 14: 289-291.

Marignier R, De Seze J, Vukusic S, Durand-Dubief F, Zephir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C. NMO-IgG and Devic’s neuromyelitis optica: a French experience. Multiple Sclerosis 2008; 14: 440-445.

Vukusic S, Van Bockstael V, Gosselin S, Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. Journal of Neurology, Neurosurgery and Psychiatry 2007; 78: 707-709.

Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, and Confavreux C, for the Adult Neurology Departments KIDMUS Study Group. Natural history of multiple sclerosis with childhood onset. The New England Journal of Medicine 2007; 356: 2603-2613.

Vukusic C, Confavreux C. Natural history of multiple sclerosis: risk factors and prognostic indicators. Curr Opin Neurol 2007; 20: 269-274.

Confavreux C, Vukusic S. Reply to: Age at disability milestones in multiple sclerosis and history of multiple sclerosis: a unifying concept. Brain 2006; 129: e57.

Vukusic S, Confavreux C. Pregnancy and multiple sclerosis: the children of Prims. Clinical Neurology and Neurosurgery 2006; 108: 266-270.

Confavreux C, Vukusic S. Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clinical Neurology and Neurosurgery 2006; 108: 327-332.

Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129: 606-616. Editorial: Compston A. Making progress on the natural history of multiple sclerosis. Brain 2006; 129: 561-563.

Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006; 129: 595-605. Editorial: Compston A. Making progress on the natural history of multiple sclerosis. Brain 2006; 129: 561-563.

Confavreux C. Vaccination contre l'hépatite B et sclérose en plaques. La Presse Médicale 2005; 34: 1205-1208.

El Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C. Steroid hormones in multiple sclerosis. Journal of Neurological Sciences 2005; 233: 49-54.

Confavreux C, Vukusic S, Arbizu T, Brochet B, Clanet M, Edan G, Kappos L, Suissa S. Sclérose en plaques et vaccination contre l’hépatite B chez l’adulte : le point en 2004. Réponse à O. Gout et O. Lyon-Caen. Revue Neurologique 2005; 161: 644-647.

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sorensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sa M, Salemi G, Savettieri G, Hillert J, Compston DA. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.

Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung H-P, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C for the Evaluation of the EDMUS system (EVALUED) Study Group: European validation of a standardized clinical description of multiple sclerosis. Journal of Neurology 2004; 251: 1472-1480.

Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, and the Pregnancy in Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127: 1353-1360.

Confavreux C, Vukusic S. Accumulation of irreversible disability in multiple sclerosis: lessons from natural history studies and therapeutic trials. Journal of the Royal College of Physicians of Edinburgh 2004; 34: 268-273.

Confavreux C. Editorial: Intravenous immunoglobulins, pregnancy and multiple sclerosis. Journal of Neurology 2004; 251: 1138-1139.

Vukusic S, Confavreux C. Primary and secondary progressive multiple sclerosis. Journal of the Neurological Sciences 2004; 206: 153-155.

Mikaeloff Y, Adamsbaum C, Husson B, Vallée L, Ponsot G, Confavreux C, Tardieu M, Suissa S, and the KIDMUS study group on Radiology. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004; 124: 1942-1947.

Mikaeloff Y, Suissa S, Vallée L, Lubetzki C, Ponsot G, Confavreux C, Tardieu M, and the KIDMUS Study Group. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. Journal of Pediatrics 2004; 144: 246-252.

Confavreux C, Vukusic S. Non-specific immunosuppressants in the treatment of multiple sclerosis. Clinical Neurology and Neurosurgery 2004; 104: 263-269.

Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-782.
(Editorial: Rodriguez M. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain 2003; 126: 751-752).

Waubant E, Vukusic S, Durand-Dubief F, Achiti I, Blanc S, Renoux C and Confavreux C. Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology 2003; 61: 184-9.

Vukusic S, Confavreux C. Primary and secondary progressive multiple sclerosis. J Neurol Sci 2003; 206: 153-5.

Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 2003; 206: 135-7.

Confavreux C. Relapses, progression, inflammation and neurodegeneration in multiple sclerosis: a changing view. Advances in Clinical Neuroscience and Rehabilitation 2002; 2: 7-9.

Confavreux C, Vukusic S. Natural History of Multiple Sclerosis: implications for counselling and therapy. Current Opinion in Neurology 2002; 15: 257-266.

Confavreux C, Suissa S, Saddier P. Vaccinations and multiple sclerosis. The New England Journal of Medicine 2001; 344: 1795-1796 (letter).

Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S, and the Vaccines in Multiple Sclerosis Group. Vaccinations and the risk of relapse in multiple sclerosis. The New England Journal of Medicine 2001; 344:319-326.
(Editorial: Gellin BG. The risk of vaccination: the importance of "negative" studies. The New England Journal of Medicine 2001; 344: 372-373).

Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. The New England Journal of Medicine 2000; 343: 1430-1438.
(Editorial: McDonald WI (2000). Relapse, remission, and progression in multiple sclerosis. The New England Journal of Medicine 2000; 343: 1486-1487).

Grimaud J, Amato MP and Confavreux C for the EVALUED Study Group. Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. Multiple Sclerosis 1999; 5: 234-238.

Confavreux C, Vukusic S, Grimaud J, Moreau T. Clinical progression and decision making process in multiple sclerosis. Multiple Sclerosis 1999; 5: 212-215.

Confavreux C, Hutchinson M , Hours MM, Cortinovis-Tourniaire P, Moreau T, and the Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. The New England Journal of Medicine 1998; 339: 285-291.
(Editorial: Whitaker JN. Effects of pregnancy and delivery on disease activity in multiple sclerosis. The New England Journal of Medicine 1998; 339: 339-340).

Confavreux C, Paty DW. Current status of computerization of multiple sclerosis clinical data for research in Europe and North America: the EDMUS / MS-COSTAR connection. Neurology 1995; 45: 573-576.

Confavreux C. Establishment and use of multiple sclerosis registers-EDMUS. Annals of Neurology 1994; 36: S136-S139.

Confavreux C, Compston DAS, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European Database for Multiple Sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 671-676.

Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
(Editorial: The prognosis of multiple sclerosis. British Medical Journal 1980; 281: 824-825).